Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 44% ± 13% | |
lung | 10 studies | 29% ± 10% | |
brain | 8 studies | 34% ± 15% | |
intestine | 5 studies | 27% ± 11% | |
bone marrow | 4 studies | 34% ± 11% | |
lymph node | 4 studies | 42% ± 15% | |
liver | 4 studies | 39% ± 9% | |
uterus | 3 studies | 20% ± 3% | |
breast | 3 studies | 22% ± 5% | |
adipose | 3 studies | 26% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 1603.04 | 359 / 359 | 100% | 29.77 | 286 / 286 |
esophagus | 100% | 2149.71 | 1444 / 1445 | 100% | 29.72 | 183 / 183 |
lung | 100% | 5245.48 | 578 / 578 | 100% | 20.95 | 1154 / 1155 |
intestine | 100% | 2832.41 | 966 / 966 | 100% | 25.53 | 526 / 527 |
bladder | 100% | 2676.52 | 21 / 21 | 100% | 21.16 | 503 / 504 |
breast | 100% | 2236.02 | 459 / 459 | 100% | 23.72 | 1114 / 1118 |
uterus | 100% | 2203.74 | 170 / 170 | 100% | 19.88 | 457 / 459 |
brain | 99% | 1656.16 | 2624 / 2642 | 100% | 18.58 | 705 / 705 |
skin | 100% | 3287.22 | 1808 / 1809 | 99% | 27.65 | 469 / 472 |
ovary | 100% | 1908.82 | 180 / 180 | 99% | 15.42 | 427 / 430 |
thymus | 100% | 2195.48 | 652 / 653 | 99% | 15.30 | 599 / 605 |
adrenal gland | 100% | 2121.79 | 258 / 258 | 98% | 15.52 | 226 / 230 |
kidney | 100% | 1392.60 | 89 / 89 | 98% | 17.78 | 885 / 901 |
prostate | 100% | 1974.08 | 245 / 245 | 98% | 12.33 | 491 / 502 |
pancreas | 94% | 890.55 | 308 / 328 | 99% | 19.92 | 176 / 178 |
liver | 100% | 1044.80 | 225 / 226 | 86% | 8.33 | 350 / 406 |
adipose | 100% | 2669.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2300.59 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 55.40 | 29 / 29 |
spleen | 100% | 5957.62 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.32 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.12 | 1 / 1 |
peripheral blood | 100% | 11278.41 | 928 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 10.78 | 73 / 80 |
heart | 86% | 869.57 | 737 / 861 | 0% | 0 | 0 / 0 |
muscle | 66% | 512.92 | 529 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0035265 | Biological process | organ growth |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0001841 | Biological process | neural tube formation |
GO_0035329 | Biological process | hippo signaling |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0007165 | Biological process | signal transduction |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_1903945 | Biological process | positive regulation of hepatocyte apoptotic process |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_1902043 | Biological process | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO_0046621 | Biological process | negative regulation of organ growth |
GO_0003157 | Biological process | endocardium development |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_1904237 | Biological process | positive regulation of substrate-dependent cell migration, cell attachment to substrate |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0051262 | Biological process | protein tetramerization |
GO_0001569 | Biological process | branching involved in blood vessel morphogenesis |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0050821 | Biological process | protein stabilization |
GO_0097284 | Biological process | hepatocyte apoptotic process |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0006606 | Biological process | protein import into nucleus |
GO_0007417 | Biological process | central nervous system development |
GO_0060706 | Biological process | cell differentiation involved in embryonic placenta development |
GO_0006915 | Biological process | apoptotic process |
GO_0060800 | Biological process | regulation of cell differentiation involved in embryonic placenta development |
GO_0000902 | Biological process | cell morphogenesis |
GO_0006468 | Biological process | protein phosphorylation |
GO_0043408 | Biological process | regulation of MAPK cascade |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0060215 | Biological process | primitive hemopoiesis |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0043539 | Molecular function | protein serine/threonine kinase activator activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | STK4 |
Protein name | Serine/threonine kinase 4 Serine/threonine-protein kinase 4 (EC 2.7.11.1) Serine/threonine-protein kinase 4 Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] |
Synonyms | MST1 KRS2 |
Description | FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation (By similarity). Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. . |
Accessions | F5H5B4 ENST00000372801.5 [Q13043-2] ENST00000474717.3 A0A087WVN8 ENST00000698220.1 ENST00000487587.3 ENST00000372806.8 [Q13043-1] Q13043 ENST00000698224.1 A0A087WYT4 ENST00000698219.1 ENST00000499879.7 A0A8V8TLH7 ENST00000698218.1 A0A8V8TNA0 A0A8V8TLK1 ENST00000698222.1 A0PJ51 ENST00000698221.1 A0A8V8TM18 A0A8V8TM13 A0A8V8TN08 |